Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy - PubMed (original) (raw)

. 1988 Nov 18;260(19):2864-71.

Affiliations

PMID: 3184351

Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy

R Klein et al. JAMA. 1988.

Abstract

The relationship between hyperglycemia, measured by glycosylated hemoglobin at the initial examination, and the four-year incidence and progression of diabetic retinopathy was examined in a population-based study in Wisconsin. Younger- (n = 891) and older-onset (n = 987) persons participating in baseline and follow-up examinations were included. Glycosylated hemoglobin was measured by microcolumn. Retinopathy was determined from stereoscopic fundus photographs. In the younger-onset group, comparing the highest with the lowest quartile of glycosylated hemoglobin, the relative risk for developing any diabetic retinopathy was 1.9; for proliferative retinopathy, 21.8; and for progression, 4.0. Among older-onset persons taking insulin, the corresponding relative risks were 1.9, 4.0, and 2.1. Among older-onset persons not taking insulin, relative risks were 4.0 for any retinopathy and 6.2 for progression. A positive relationship between incidence and progression of retinopathy and glycosylated hemoglobin remained after controlling for duration of diabetes, age, sex, and baseline retinopathy. These data suggest a strong and consistent relationship between hyperglycemia and incidence and progression of retinopathy.

PubMed Disclaimer

Cited by

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.
Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Hammes HP, et al. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11555-8. doi: 10.1073/pnas.88.24.11555. Proc Natl Acad Sci U S A. 1991. PMID: 1763069 Free PMC article.
Coronary heart disease and diabetic retinopathy in newly diagnosed diabetes in Da Qing, China: the Da Qing IGT and Diabetes Study.
Hu YH, Pan XR, Liu PA, Li GW, Howard BV, Bennett PH. Hu YH, et al. Acta Diabetol. 1991;28(2):169-73. doi: 10.1007/BF00579721. Acta Diabetol. 1991. PMID: 1777654
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for the Study of Diabetes. Nathan DM, et al. Diabetologia. 2009 Jan;52(1):17-30. doi: 10.1007/s00125-008-1157-y. Epub 2008 Oct 22. Diabetologia. 2009. PMID: 18941734
Retinal vascular changes and diabetic retinopathy.
Nguyen TT, Wong TY. Nguyen TT, et al. Curr Diab Rep. 2009 Aug;9(4):277-83. doi: 10.1007/s11892-009-0043-4. Curr Diab Rep. 2009. PMID: 19640340 Review.
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Nathan DM, et al. N Engl J Med. 2005 Dec 22;353(25):2643-53. doi: 10.1056/NEJMoa052187. N Engl J Med. 2005. PMID: 16371630 Free PMC article. Clinical Trial.

Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy - PubMed (original) (raw)